MeReC Extra examines benefits and risks of oseltamivir (Tamiflu®) - NeLM

Homepage

Login | Register

Search the NeLM

Medicines A-Z

Find key information about medicines by name (prototype)

Browse by Categories:

Browse by NeLM area:

NeLM news service

MeReC Extra examines benefits and risks of oseltamivir (Tamiflu®)

Reference: MeReC Extra November 2009: no. 42

Source: MeReC Extra

Date published: 20/11/2009 16:25

Summary

by: Yuet Wan

The benefits and risks of oseltamivir (Tamiflu®) for the treatment of influenza is the subject of the November edition of MeReC Extra.

About this library entry

Category: 5.3.4 Influenza | Drug reviews | Infection control | Public Health | Viral

NeLM area: News

Link to MeReC Extra November 2009: no. 42

Preview your comment

Add new comment

Comment text:

Comments

There are no comments yet. You could be the first! You must be Logged In to comment.

Printer Friendly Version

Related evidence

5.3.4 Influenza

25/08/2009

CKS Topic Minibite: Seasonal influenza

24/09/2008

NICE issues guidance on oseltamivir, amantadine and zanamivir for the prophylaxis of influenza

25/02/2004

Chronic obstructive pulmonary disease: NICE Guideline

Infection control

26/09/2011

Colony-stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemia

19/01/2010

Cochrane review: Peri-operative glycaemic control regimens for preventing surgical site infections in adults

30/01/2009

Does vancomycin prescribing intervention affect vancomycin-resistant enterococcus infection and colonization in hospitals: a systematic review

Viral

07/10/2011

Updated PRODIGY (formerly CKS) topics on seasonal influenza and seasonal influenza immunisations

06/09/2011

AWMSG issues Final Appraisal Recommendation on valganciclovir

05/05/2011

Routine vitamin A supplementation for the prevention of blindness due to measles infection in children

Related news

5.3.4 Influenza

08/02/2012

CADTH rapid response report: Antivirals for pandemic and human avian influenzas

23/01/2012

NHS Choices publishes assessment of reports casting doubt over the efficacy of oseltamivir (Tamiflu®)

23/01/2012

BMJ publishes articles discussing the Cochrane review on oseltamivir and its implications

Infection control

09/02/2012

CMO issues infection control advice on Pseudomonas aeruginosa

09/02/2012

NHS Choices assessment of press reports on difficulty in identifying how Clostridium difficile spreads in hospital

12/01/2012

AWMSG Statement of Advice: Telavancin (Vibativ®) for the treatment of adults with nosocomial pneumonia

Viral

01/02/2012

Increased transmission and outbreaks of measles in the European Region

30/01/2012

Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases

24/01/2012

A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in children

Back